BCL6 and diffuse large B-cell lymphoma: GEPs were measured using the Affymetrix HG-U95A GeneChip platform with DLBCL and CLL cell lines (LY7, Pfeiffer and VAL cell lines), where cells were infected with control non-target shRNA or validated shRNA targeting BCL6.